市場調査レポート

商品コード

1793483

多発性硬化症治療デバイスの世界市場：タイプ・治療デバイス・エンドユーザー・地域別 (～2032年)

Global Multiple Sclerosis Treatment Devices Market Research Report by Type, by Treatment Devices, by End User, and by Region Forecast till 2032

出版日: 2025年07月08日
発行: Market Research Future
ページ情報: 英文 165 Pages
納期: 即納可能

価格

PDF & Excel (Single User License)

USD 4,950 734,827円

レポートPDF、Excelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Multi User License)

USD 5,950 883,277円

レポートPDF、Excelを同一企業内の最大15名がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Enterprise License)

USD 7,250 1,076,262円

レポートPDF、Excelを同一企業内のすべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDF、Excelの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.45円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

多発性硬化症治療デバイスの市場規模は、8億1,358万米ドルから、2032年には12億6,387万米ドルに成長すると予測されます。多発性硬化症治療デバイスとは、多発性硬化症患者が筋力低下、痙縮、バランス障害、慢性疼痛に対処するのを助けるために開発された医療機器を指します。その範囲は神経刺激装置からロボット歩行訓練機、機能的電気刺激 (FES) システムにまで及びます。これらは移動を支援し、症状の重症度を軽減することで、従来の薬物療法を補完します。

世界の多発性硬化症治療デバイス市場は着実に拡大しており、その要因は疾病の有病率上昇と支援医療技術における革新です。多発性硬化症は中枢神経系に影響を及ぼし、北米および欧州で症例数が多く、カナダでは人口10万人あたり約288例が報告されています。

最新の治療デバイスは患者ケアを変革しており、特に脊髄刺激 (SCS) 、経頭蓋磁気刺激 (TMS) 、ウェアラブル型FESシステムといった高度な神経刺激ツールが注目されています。これらのデバイスは、患者が再び歩行能力を取り戻し、痙縮を軽減し、疼痛を緩和することを可能にします。最近の革新にはAIとセンサーに基づくモニタリングが組み込まれており、患者のリアルタイムの状態に応じて調整されるオーダーメイド治療を提供できます。スマートエクソスケルトン、ロボット支援歩行訓練機、センサー内蔵テキスタイルはリハビリに新たな可能性をもたらしています。

しかし依然として、市場は低・中所得国の状況による課題に直面しています。これには、認知度の低さ、十分な診断インフラの欠如、価格の負担が含まれます。一方で、病院、医療機器企業、リハビリ専門家の戦略的パートナーシップがこのギャップを埋めつつあります。共同開発によって、スマートFES装具、AI搭載の疼痛緩和デバイス、遠隔モニタリングプラットフォームが生まれています。これらは病院受診回数を減らし、治療コンプライアンスを高めます。研究・投資・国際保健プログラムも継続しており、これらの技術は将来的に多発性硬化症管理の主要な一部となる可能性が高いです。

当レポートでは、世界の多発性硬化症治療デバイスの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

概要
北米
- 米国
- カナダ
欧州
- ドイツ
- フランス
- 英国
- スペイン
- イタリア
- ロシア
- その他
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- マレーシア
- タイ
- インドネシア
- その他
南米
- ブラジル
- メキシコ
- アルゼンチン
- その他
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他

第9章競合情勢

市場シェア分析
競合ダッシュボード
公開企業の株式：サマリー
比較分析：主要企業の財務動向
主な展開・成長戦略

第10章企業プロファイル

ENOVIS
AXONICS, INC.
KONINKLIJKE PHILIPS N.V.
BTL
BAYER AG
MEDTRONIC
ABBOTT
BOSTON SCIENTIFIC CORPORATION
BIOTRONIK
SALUDA MEDICAL PTY LTD.

第11章データの引用

図表

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 3 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS), BY REGION, 2019-2032 (USD MILLION)
TABLE 4 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS), BY REGION, 2019-2032 (USD MILLION)
TABLE 5 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS), BY REGION, 2019-2032 (USD MILLION)
TABLE 6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR CLINICALLY ISOLATED SYNDROME (CIS), BY REGION, 2019-2032 (USD MILLION)
TABLE 7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES, 2019-2032 (USD MILLION)
TABLE 8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY REGION, 2019-2032 (USD MILLION)
TABLE 9 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 10 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR FUNCTIONAL ELECTRICAL STIMULATION (FES), BY REGION,2019-2032 (USD MILLION) REGION
TABLE 11 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS), BY REGION, 2019-2032 (USD MILLION)
TABLE 12 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY REGION, 2019-2032 (USD MILLION) 56 REGION
TABLE 13 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 14 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR SPINAL CORD STIMULATION (SCS), BY REGION, 2019-2032 (USD MILLION) 57 REGION
TABLE 15 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR DEEP BRAIN STIMULATION (DBS), BY REGION, 2019-2032 (USD MILLION) 58 REGION
TABLE 16 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 17 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION) 60 REGION
TABLE 18 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD MILLION) 61 REGION
TABLE 19 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 20 NORT AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 21 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 22 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
TABLE 23 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 24 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 25 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 26 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 27 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
TABLE 28 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 29 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 30 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 31 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 32 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
TABLE 33 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 34 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 35 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 36 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 37 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 38 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
TABLE 39 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 40 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 41 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 42 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 43 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
TABLE 44 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 45 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 46 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 47 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 48 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
TABLE 49 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 50 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 51 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 52 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 53 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
TABLE 54 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 55 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 56 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 57 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 58 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
TABLE 59 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 60 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 61 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 62 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 63 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
TABLE 64 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 65 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 66 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 67 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 68 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
TABLE 69 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 70 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 71 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 72 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 73 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
TABLE 74 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019 2032 (USD MILLION)
TABLE 75 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 76 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 77 ASIA PACIFIC MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 78 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 79 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 80 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 81 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 82 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 83 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 84 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 85 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 86 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 87 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 88 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 89 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 90 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019 2032 (USD MILLION)
TABLE 91 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 92 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 93 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 94 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 95 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 96 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019 - 2032 (USD MILLION)
TABLE 97 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 98 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 99 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 100 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 101 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 102 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 103 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 104 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 105 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 106 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019 2032 (USD MILLION)
TABLE 107 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 108 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 109 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 110 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 111 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019 2032 (USD MILLION)
TABLE 112 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 113 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 114 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 115 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 116 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE,
TABLE 117 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 118 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 119 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 120 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 121 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 122 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 123 SOUTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 124 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 125 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 126 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 127 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 128 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 129 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 130 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 131 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 132 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019 2032 (USD MILLION)
TABLE 133 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 134 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 135 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 136 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 137 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019 2032 (USD MILLION)
TABLE 138 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 139 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 140 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 141 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 142 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 143 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 144 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 145 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 146 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 147 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 148 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 149 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 150 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 151 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 152 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 153 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 154 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 155 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 156 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 157 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 158 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 159 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 160 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 161 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 162 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 163 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 164 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 165 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 166 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
TABLE 167 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 168 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 169 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 170 PRODUCT LAUNCH
TABLE 171 PRODUCT APPROVAL
TABLE 172 ENOVIS: PRODUCTS OFFERED
TABLE 173 AXONICS, INC.: PRODUCTS OFFERED
TABLE 174 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 175 BTL: PRODUCT OFFERED
TABLE 176 BAYER AG: PRODUCTS OFFERED
TABLE 177 MEDTRONIC: PRODUCTS OFFERED
TABLE 178 MEDTRONIC: KEY DEVELOPMENTS
TABLE 179 ABBOTT: PRODUCTS OFFERED
TABLE 180 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 181 ABBOTT: KEY DEVELOPMENTS
TABLE 182 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 183 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET: STRUCTURE
FIGURE 2 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2022-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET
FIGURE 6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET; TYPE SEGMENT ATTRACTIVENESS, (USD MILLION)
FIGURE 7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2023 & 2032 (USD MILLION)
FIGURE 8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY TYPE, 2023
FIGURE 9 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET; TREATMENT DEVICES SEGMENT ATTRACTIVENESS, (USD MILLION)
FIGURE 10 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES, 2023 & 2032 (USD MILLION)
FIGURE 11 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY TREATMENT DEVICES, 2023
FIGURE 12 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET; END USER SEGMENT ATTRACTIVENESS, (USD MILLION)
FIGURE 13 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 14 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY END USER, 2023
FIGURE 15 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 16 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY REGION, 2023
FIGURE 17 NORTH AMERICA MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, 2019-2032 (USD MILLION)
FIGURE 18 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 19 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 20 EUROPE MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, 2019-2032 (USD MILLION)
FIGURE 21 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 22 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 23 ASIA PACIFIC MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, 2019-2032 (USD MILLION)
FIGURE 24 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 25 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 26 SOUTH AMERICA MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, 2019-2032 (USD MILLION)
FIGURE 27 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 28 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 29 MIDDLE EAST AND AFRICA MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, 2019-2032 (USD MILLION)
FIGURE 30 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 31 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 32 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023
FIGURE 33 COMPETITOR DASHBOARD: GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET
FIGURE 34 ENOVIS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 ENOVIS: SWOT ANALYSIS
FIGURE 36 AXONICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS
FIGURE 39 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 MEDTRONIC: SWOT ANALYSIS
FIGURE 42 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 43 ABBOTT: SWOT ANALYSIS
FIGURE 44 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

Product Code: MRFR/HC/57635-CR

Global Multiple Sclerosis Treatment Devices Market Research Report by Type [Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Relapsing-remitting Multiple Sclerosis (RRMS), Clinically Isolated Syndrome (CIS)], by Treatment Devices [Electrical Stimulation Devices (Functional Electrical Stimulation (FES), Transcutaneous Electrical Nerve Stimulation (TENS)), Neurostimulation Devices (Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS))], by End User (Hospitals & Clinics, Ambulatory Surgical Centers), and by Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Forecast till 2032

Industry Overview

The multiple sclerosis treatment devices market stood at USD 813.58 million and is expected to grow to USD 1,263.87 million by 2032. MS treatment devices refer to medical equipment developed to assist people living with Multiple Sclerosis in coping with muscle weakness, spasticity, balance issues, and chronic pain. They range from neurostimulation devices to robotic gait trainers and functional electrical stimulation systems. By supporting mobility and reducing symptom severity, they complement traditional drug-based therapies.

The Global Multiple Sclerosis (MS) Treatment Devices market is expanding steadily, propelled by rising disease prevalence and innovation in assistive medical technologies. MS affects the central nervous system, with higher cases in North America and Europe. Canada has about 288 cases per 100,000 people.

Modern treatment devices are transforming patient care, particularly advanced neurostimulation tools like spinal cord stimulation (SCS), transcranial magnetic stimulation (TMS), and wearable functional electrical stimulation (FES) systems. These devices enable the patients to regain mobility, decrease spasticity, and alleviate pain. The recent innovations combine AI and sensor-based monitoring, which enable a patient to receive a custom-made therapy that changes according to his or her real-time condition. Smart exoskeletons, robotic-assisted gait trainers, and sensor-embedded textiles are coming up with new opportunities in rehabilitation.

However, still, there are still some barriers that the market is facing due to the conditions of low- and middle-income countries. These include limited awareness, a lack of enough diagnostic infrastructure, and affordability issues. On the other hand, strategic partnerships between hospitals, med-tech companies, and rehabilitation specialists are creating ways to cover this gap. Collaborations are resulting in the creation of smart FES braces, AI-powered pain relief devices, and remote monitoring platforms, which not only reduce hospital visits but also improve treatment compliance. Research, investment, and global health programs are continuing, and these technologies will likely be the main parts of MS management in the future.

Industry Segmentations

The global multiple sclerosis treatment devices market is classified based on the type, comprising primary progressive multiple sclerosis, secondary progressive multiple sclerosis, relapsing-remitting multiple sclerosis, and clinically isolated syndrome.

In terms of the treatment devices, the global market is segmented into electrical stimulation devices and neurostimulation devices. Functional electrical stimulation and transcutaneous electrical nerve stimulation are further segments of the ESD. Spinal cord stimulation and deep brain stimulation are parts of neurostimulation devices.

Based on the end users, the global multiple sclerosis treatment devices market is divided into hospitals & clinics, and ambulatory surgical centers.

Regional Analysis

Demand is largely shaped by consumer preference for premium and durable goods in the North American region. The upholstery sector in the U.S. automotive industry is the major volume driver, while luxury handbags and footwear brands are the main contributors to consumption of higher value. The growth in e-commerce has not only increased the scale but also the geographic scope of niche leather goods producers. Sustainability labeling is becoming a market differentiator.

Craftsmanship, quality, and sustainability are the first and foremost to European buyers. High-end fashion leather production in Italy and France reigns supreme, while Germany's automotive fleet demands precision-processed hides. Green certifications and traceable sourcing are key to market acceptance. Seasonal fashion cycles keep demand steady year-round.

Leather in APAC is required not only for the export of goods but also for the purpose of meeting the needs of growing domestic consumption. China's fashion and automotive markets are hot for mid-to-premium leather products. India balances large-scale export tanning with a rising domestic shoe industry. Technological upgrades in tanning processes are improving quality standards.

Durability and style have made leather the favorite of consumers, particularly in footwear and accessories. The domestic market of Brazil is in line with its export strength, while Argentina is still known for its premium craftsmanship. The shifts in the economy affect the buying power, but the exports hold steady owing to the competitive pricing.

The luxury retail sector in the Gulf states sustains high demand for imported premium leather goods. Africa's emerging middle class is slowly increasing domestic demand. Government incentives in countries like Ethiopia aim to grow local leather processing capacity. However, consumer preference still leans towards imported finished products.

Key Players

Key competitors in the global multiple sclerosis treatment devices market are Medtronic, Abbott, Boston Scientific Corporation, Biotronik, Saluda Medical Pty Ltd., Enovis, Bayer, Koninklijke Philips N.V., BTL, and Axonics Inc.

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION
3.10 INTRODUCTION
3.11 DRIVERS
- 3.11.1 INCREASING PREVALENCE OF MULTIPLE SCLEROSIS (MS)
- 3.11.2 ADVANCEMENTS IN NEUROSTIMULATION AND WEARABLE DEVICES
3.12 RESTRAINTS
- 3.12.1 LIMITED AWARENESS AND ACCESSIBILITY IN DEVELOPING REGIONS
3.13 OPPORTUNITY
- 3.13.1 RISING COLLABORATIONS BETWEEN HEALTHCARE PROVIDERS AND TECHNOLOGY FIRMS

4 MARKET FACTOR ANALYSIS

4.1 PORTER'S FIVE FORCES MODEL
- 4.1.1 THREAT OF NEW ENTRANTS
- 4.1.2 BARGAINING POWER OF SUPPLIERS
- 4.1.3 THREAT OF SUBSTITUTES
- 4.1.4 BARGAINING POWER OF BUYERS
- 4.1.5 INTENSITY OF RIVALRY
4.2 IMPACT OF COVID-19 ON THE GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET

5 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE

5.1 OVERVIEW
5.2 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS)
5.3 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS)
5.4 RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)
5.5 CLINICALLY ISOLATED SYNDROME (CIS)

6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES

6.1 INTRODUCTION
6.2 ELECTRICAL STIMULATION DEVICES
- 6.2.1 FUNCTIONAL ELECTRICAL STIMULATION (FES)
- 6.2.2 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
6.3 NEUROSTIMULATION DEVICES
- 6.3.1 SPINAL CORD STIMULATION (SCS)
- 6.3.2 DEEP BRAIN STIMULATION (DBS)

7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER

7.1 OVERVIEW
7.2 HOSPITALS & CLINICS
7.3 AMBULATORY SURGICAL CENTERS

8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET BY REGION

8.1 OVERVIEW
8.2 NORTH AMERICA
- 8.2.1 US
- 8.2.2 CANADA
8.3 EUROPE
- 8.3.1 GERMANY
- 8.3.2 FRANCE
- 8.3.3 UK
- 8.3.4 SPAIN
- 8.3.5 ITALY
- 8.3.6 RUSSIA
- 8.3.7 REST OF EUROPE
8.4 ASIA PACIFIC
- 8.4.1 CHINA
- 8.4.2 INDIA
- 8.4.3 JAPAN
- 8.4.4 SOUTH KOREA
- 8.4.5 MALAYSIA
- 8.4.6 THAILAND
- 8.4.7 INDONESIA
- 8.4.8 REST OF ASIA PACIFIC
8.5 SOUTH AMERICA
- 8.5.1 BRAZIL
- 8.5.2 MEXICO
- 8.5.3 ARGENTINA
- 8.5.4 REST OF SOUTH AMERICA
8.6 MIDDLE EAST AND AFRICA
- 8.6.1 GCC COUNTRIES
- 8.6.2 SOUTH AFRICA
- 8.6.3 REST OF MEA

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION
9.2 MARKET SHARE ANALYSIS, 2023
9.3 COMPETITOR DASHBOARD
9.4 PUBLIC PLAYERS STOCK SUMMARY
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
9.1 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 9.1.1 PRODUCT LAUNCH
- 9.1.2 PRODUCT APPROVAL

10 COMPANY PROFILES

10.1 ENOVIS
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL OVERVIEW
- 10.1.3 PRODUCTS OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.1.6 KEY STRATEGIES
10.2 AXONICS, INC.
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 PRODUCTS OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 KEY STRATEGIES
10.3 KONINKLIJKE PHILIPS N.V.
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 PRODUCTS OFFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 SWOT ANALYSIS
- 10.3.6 KEY STRATEGIES
10.4 BTL
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 PRODUCTS OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 KEY STRATEGIES
10.5 BAYER AG
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL OVERVIEW
- 10.5.3 PRODUCTS OFFERED
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 KEY STRATEGY
10.6 MEDTRONIC
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 PRODUCTS OFFERED
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 SWOT ANALYSIS
- 10.6.6 KEY STRATEGIES
10.7 ABBOTT
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 PRODUCTS OFFERED
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 SWOT ANALYSIS
- 10.7.6 KEY STRATEGIES
10.8 BOSTON SCIENTIFIC CORPORATION
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 PRODUCTS OFFERED
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 KEY STRATEGIES
10.9 BIOTRONIK
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 PRODUCTS OFFERED
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 KEY STRATEGIES
10.10 SALUDA MEDICAL PTY LTD.
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 PRODUCTS OFFERED
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 KEY STRATEGIES

11 DATA CITATIONS

11.1 DATA CITATIONS

多発性硬化症治療デバイスの世界市場：タイプ・治療デバイス・エンドユーザー・地域別 (～2032年)

Global Multiple Sclerosis Treatment Devices Market Research Report by Type, by Treatment Devices, by End User, and by Region Forecast till 2032

目次

第1章エグゼクティブサマリー

第2章市場概要

第3章調査手法

第4章市場要因分析

第5章世界の多発性硬化症治療デバイス市場：タイプ別

第6章世界の多発性硬化症治療デバイス市場：治療デバイス別

第7章世界の多発性硬化症治療デバイス市場：エンドユーザー別

第8章世界の多発性硬化症治療デバイス市場：地域別

第9章競合情勢

第10章企業プロファイル

第11章データの引用

LIST OF TABLES

LIST OF FIGURES

Regional Analysis

Key Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET FACTOR ANALYSIS

5 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE

6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES

7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER

8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET BY REGION

9 COMPETITIVE LANDSCAPE

10 COMPANY PROFILES

11 DATA CITATIONS

多発性硬化症治療デバイスの世界市場：タイプ・治療デバイス・エンドユーザー・地域別 (～2032年)

Global Multiple Sclerosis Treatment Devices Market Research Report by Type, by Treatment Devices, by End User, and by Region Forecast till 2032

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場要因分析

第5章 世界の多発性硬化症治療デバイス市場：タイプ別

第6章 世界の多発性硬化症治療デバイス市場：治療デバイス別

第7章 世界の多発性硬化症治療デバイス市場：エンドユーザー別

第8章 世界の多発性硬化症治療デバイス市場：地域別

第9章 競合情勢

第10章 企業プロファイル

第11章 データの引用

LIST OF TABLES

LIST OF FIGURES

Regional Analysis

Key Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET FACTOR ANALYSIS

5 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE

6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES

7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER

8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET BY REGION

9 COMPETITIVE LANDSCAPE

10 COMPANY PROFILES

11 DATA CITATIONS

第1章エグゼクティブサマリー

第2章市場概要

第3章調査手法

第4章市場要因分析

第5章世界の多発性硬化症治療デバイス市場：タイプ別

第6章世界の多発性硬化症治療デバイス市場：治療デバイス別

第7章世界の多発性硬化症治療デバイス市場：エンドユーザー別

第8章世界の多発性硬化症治療デバイス市場：地域別

第9章競合情勢

第10章企業プロファイル

第11章データの引用